These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31343326)

  • 21. From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
    Petkow-Dimitrow P; Rajtar-Salwa R; Holcman K; Kostkiewicz M; Rubiś P
    Pol Arch Intern Med; 2020 Feb; 130(2):153-154. PubMed ID: 31933485
    [No Abstract]   [Full Text] [Related]  

  • 22. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitreous opacities in a case of familial amyloidotic polyneuropathy associated with a transthyretin Lys 54.
    Imasawa M; Toda Y; Sakurada Y; Imai M; Iijima H
    Acta Ophthalmol Scand; 2004 Oct; 82(5):635-7. PubMed ID: 15453875
    [No Abstract]   [Full Text] [Related]  

  • 24. Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.
    Alcantara M; Mezei MM; Baker SK; Breiner A; Dhawan P; Fiander A; Fine NM; Hahn C; Katzberg HD; Khayambashi S; Massie R; Matte G; Putko B; Siddiqi Z; Delgado D; Bril V
    Can J Neurol Sci; 2022 Jan; 49(1):7-18. PubMed ID: 33631091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45Asp.
    Misumi Y; Doki T; Ueda M; Obayashi K; Tasaki M; Tamura A; Ando Y
    Amyloid; 2014 Sep; 21(3):216-7. PubMed ID: 24953234
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.
    Damy T; Plante-Bordeneuve V; Dogan A
    Arch Cardiovasc Dis; 2014 Dec; 107(12):706-8. PubMed ID: 24070596
    [No Abstract]   [Full Text] [Related]  

  • 27. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
    Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
    Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
    Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis.
    Ando Y; Ueda M
    Front Biosci; 2008 May; 13():5548-58. PubMed ID: 18508604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy.
    Ruzhansky K; Scoon J; Weimer LH; Maurer MS; Berk JL; Brannagan TH
    J Clin Neuromuscul Dis; 2014 Sep; 16(1):1-6. PubMed ID: 25137508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transthyretin-related familial amyloidotic polyneuropathy found with abnormal urinalysis at a general health checkup.
    Yoshimura Y; Kuwabara T; Shiraishi N; Kakizoe Y; Tasaki M; Obayashi K; Ando Y; Mukoyama M
    Nephrology (Carlton); 2016 Apr; 21(4):341-2. PubMed ID: 27028416
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis.
    Lau KHV; Prokaeva T; Zheng L; Doros G; Kaku MC; Spencer B; Berk J; Sanchorawala V
    Amyloid; 2024 Jun; 31(2):150-152. PubMed ID: 38073425
    [No Abstract]   [Full Text] [Related]  

  • 33. Coexistence of transthyretin familial amyloid polyneuropathy and hereditary neuropathy with liability to pressure palsy.
    Conceição I; Nzwalo H; de Carvalho M
    Clin Neurol Neurosurg; 2012 Dec; 114(10):1355-7. PubMed ID: 22520972
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac involvement after liver transplantation in patients with Val30Met transthyretin amyloidosis from Majorca focus.
    Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
    Amyloid; 2019; 26(sup1):18-19. PubMed ID: 31343328
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hereditary transthyretin amyloidosis].
    Hund E
    Nervenarzt; 2014 Oct; 85(10):1291-7. PubMed ID: 25123367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
    Obici L; Berk JL; González-Duarte A; Coelho T; Gillmore J; Schmidt HH; Schilling M; Yamashita T; Labeyrie C; Brannagan TH; Ajroud-Driss S; Gorevic P; Kristen AV; Franklin J; Chen J; Sweetser MT; Wang JJ; Adams D
    Amyloid; 2020 Sep; 27(3):153-162. PubMed ID: 32131641
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
    Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
    Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
    [No Abstract]   [Full Text] [Related]  

  • 38. Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis.
    Mahfouz M; Maruyama R; Yokota T
    Methods Mol Biol; 2020; 2176():87-98. PubMed ID: 32865784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 40. Misdiagnosis in late versus early onset hATTR amyloidosis patients: experience from a reference centre.
    Falcão de Campos C; Parreira S; Conceição I
    Amyloid; 2019; 26(sup1):37-38. PubMed ID: 31343293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.